This is the authors' abstract. We don't add key points for this paper.
Aim: To report outcomes of a new variable thickness intracorneal ring segment (VT-ICRS) for the treatment of keratoconus.Methods: This was a retrospective interventional case series of consecutive keratoconus eyes that underwent VT-ICRS implantation from January 2018 to December 2020 with a minimum follow-up time of 3 months.Primary outcomes included best spectacle-corrected visual acuity (BSCVA), uncorrected distance visual acuity (UCVA) and adverse events.Secondary outcomes included keratometry and manifest refraction.Results: Overall, 9 eyes of 7 patients with a mean age of 30.22 8.58 (range, 21-49 years) of which 85.7% (n = 6) were of male gender were included.The mean follow-up time was 9.0 5.3 (range, 4-17) months.No intraoperative or postoperative adverse events were identified during the follow-up period of these patients.At final follow-up, there was significant improvement in logMAR UCVA (from 0.95 0.21 to 0.34 0.31, p < 0.001), manifest sphere (from 1.11 1.69 to -0.13 0.35 D, p = 0.05), manifest cylinder (from -6.61 2.83 to -2.44 2.26 D, p < 0.001), K2 (51.94 5.43 to 49.20 5.78 D, p = 0.01), and logMAR BSCVA (from 0.35 0.10 to 0.15 0.14, p = 0.002).The mean safety index was 1.68 0.53 (range, 1-2.50) and the mean efficacy index was 1.24 0.69 (range, 0.39-2.25).Alpins refractive vector analysis revealed a mean surgically induced astigmatism (SIA) of 4.99 1.20 D (range, 3.79-7.12D) with a mean SIA axis of 96.3 42.5 (range, 25.1-142). Conclusion:The initial results of VT-ICRS for the treatment of keratoconus are encouraging.Future studies should compare VT-ICRS to classic ICRSs for the treatment of keratoconus.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Barbara et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: